Skip to main content

Where Are They Now?: Jan 1, 2003


Last January, TIGR head Claire Fraser graced the cover of Genome Technology. Inside, Fraser talked about how the institute had evolved over its decade-long existence into a microbial sequencing powerhouse. Since then, hubby Craig Venter started three new institutes to go along with the TIGR family and announced plans to turn TIGR’s sequencing facility into a high-quality closure workshop. (See last month’s GT for more on Venter’s vision.)

Also in last year’s issue: execs from Genaissance, Orchid, and Variagenics shared their know-how on setting up a large-scale SNP shop. Since then, though, the SNP scene has gotten significantly smaller. Genaissance cut 20 percent of its staff and appointed a new CEO, Orchid put its SNP instrument biz on the block, and Hyseq merged with the struggling Variagenics for its cash (see p. 19).

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.